Amicus Therapeutics, Inc.
FOLDNASDAQHealthcare
$14.49
+$0.00(+0.00%)
Market Cap$4.5B
P/E Ratio—
52W High$14.5
52W Low$5.51
Amicus Therapeutics, Inc.（FOLD）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · FOLD · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.03B) | ($0.06B) | ($0.15B) | ($0.24B) | ($0.25B) |
| Depreciation & Amort. | $0.00B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.09B | $0.08B | $0.09B | $0.08B | $0.06B |
| Change in Working Capital | ($0.04B) | ($0.10B) | ($0.05B) | ($0.04B) | ($0.02B) |
| Net Cash from Operations | $0.03B | ($0.03B) | ($0.07B) | ($0.17B) | ($0.20B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.09B) | ($0.11B) | ($0.09B) | ($0.24B) | ($0.34B) |
| Sales of Investments | $0.05B | $0.12B | $0.20B | $0.34B | $0.42B |
| Net Cash from Investing | ($0.05B) | ($0.00B) | $0.10B | $0.09B | $0.08B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | ($0.01B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.00B) | ($0.00B) | ($0.02B) | ($0.00B) | ($0.00B) |
| Net Cash from Financing | $0.00B | $0.01B | $0.06B | ($0.01B) | $0.21B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.03B | ($0.04B) | ($0.08B) | ($0.17B) | ($0.21B) |
| FCF Margin %(computed) | 4.71% | -7.09% | -19.16% | -51.74% | -67.55% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Amicus Therapeutics, Inc.
关于Amicus Therapeutics, Inc.（FOLD）现金流量表
Amicus Therapeutics, Inc. 2025财年经营活动现金流$0.03B，自由现金流$0.03B（FCF利润率4.71%），资本支出($0.00B)。
常见问题
FOLD · 4 问Amicus Therapeutics, Inc. 2025财年自由现金流$0.03B，同比up179.7%。
FOLD free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10